STAT3-IN-44
STAT3-IN-44 is a potent STAT3 inhibitor with IC50s of 1.84 (C6 cells) and 4.81 μM (A549 cells) . STAT3-IN-44 inhibits STAT3 phosphorylation, downregulates Bcl-2, and upregulates Caspase-3 to promote late-stage apoptosis. STAT3-IN-44 significantly suppresses tumor cell proliferation and migration. STAT3-IN-44 can be used for the study of cancers such as glioma and lung cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; Caspase; STAT
Related Pathways
Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
COC1=CC(/C=C/C2=CC=C(C=C2)OCC(N3CCN(CC3)CC4=CNC5=C4C=C(C=C5)Cl)=O)=CC(OC)=C1
Molecular Formula
C31H32ClN3O4
Molecular Weight
546.06
References & Citations
[1]Xiao Y, et al. Design, synthesis and evaluation of pterostilbene-indole hybrids as potential anticancer agents. Bioorg Med Chem Lett. 2025 Jun 26;128:130317.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bcl-2; Caspase 3; STAT3
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
040310-ML550 100 µL
PPFIBP1, ID (PPFIBP1, KIAA1230, Liprin-beta-1, Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1, hSGT2) (MaxLight 550) discontinued
Sign In for Pricing
View Details